-transparent.png){kind=logo}
The left anterior descending coronary artery (LAD) of the dog was ligated completely for 1.5 min, and immediately after LAD ligation the heart was taken for determination of the glycogen phosphorylase and glycogen. Trimetazidine was injected intravenously 20 min before LAD ligation. LAD ligation increased the activity of glycogen phosphorylase and decreased the level of glycogen in both ischemic (LAD) and nonischemic (circumflex) areas. Trimetazidine at the dose of 0.3 or 1.0 mg/kg, being the dose that did not affect blood pressure and heart rate markedly, inhibited the ischemia-induced changes in glycogen phosphorylase and glycogen level. It is concluded that trimetazidine inhibits the ischemia-induced increase in the utilization of glycogen in the dog myocardium.
K Sakai, and
Y Fukushi, and
Y Abiko
January 1976,
Recent advances in studies on cardiac structure and metabolism,
K Sakai, and
Y Fukushi, and
Y Abiko
January 1974,
Japanese journal of pharmacology,
K Sakai, and
Y Fukushi, and
Y Abiko
January 1979,
Circulatory shock,
K Sakai, and
Y Fukushi, and
Y Abiko
November 1981,
Japanese circulation journal,
K Sakai, and
Y Fukushi, and
Y Abiko
August 1992,
European heart journal,
K Sakai, and
Y Fukushi, and
Y Abiko
November 1975,
American heart journal,
K Sakai, and
Y Fukushi, and
Y Abiko
August 1986,
Aviation, space, and environmental medicine,
K Sakai, and
Y Fukushi, and
Y Abiko
December 2020,
Minerva medica,
K Sakai, and
Y Fukushi, and
Y Abiko
March 1972,
British journal of pharmacology,
K Sakai, and
Y Fukushi, and
Y Abiko
January 2002,
Current medical research and opinion,
